Fresenius Kabi has introduced Cetrorelix Acetate for Injection, an FDA-approved, cost-effective generic option for women’s reproductive health. The kit, available immediately, includes one single-dose vial of 0.25 mg cetrorelix, a pre-filled syringe with 1 mL sterile water for injection, a 20-gauge needle, and a 27-gauge needle.
Fresenius Kabi has launched Cetrorelix Acetate for Injection, a generic equivalent to EMD Serono’s Cetrotide® (0.25 mg). This prescription medication is used to inhibit the effects of gonadotropin-releasing hormone (GnRH) during ovarian stimulation, helping to prevent premature ovulation that can impact egg quality.
Arun Verma, president of Fresenius Kabi USA, noted that the introduction of Cetrorelix Acetate for Injection highlights the company’s commitment to enhancing access to affordable injectable medicines and supporting women’s health.
The American Society for Reproductive Medicine reports a rise in IVF births from 89,208 in 2021 to 91,771 in 2022, indicating increased demand for fertility treatments. Currently, 2.5% of all U.S. births result from assisted reproductive technology (ART) cycles.
Cetrorelix Acetate for Injection is the fourth product in Fresenius Kabi’s Women’s Health portfolio, which also includes Chorionic Gonadotropin for Injection, USP (hCG), Progesterone Injection, USP, and Ganirelix Acetate Injection. The company plans to further expand its offerings to address growing reproductive health needs.
Important Safety Information:
Cetrorelix Acetate for Injection is contraindicated in:
- Individuals with hypersensitivity to cetrorelix acetate, extrinsic peptide hormones, mannitol, or GnRH analogs.
- Pregnant or lactating women.
- Those with severe renal impairment.
- Women with severe allergic conditions.
Adverse effects reported include ovarian hyperstimulation syndrome (3.5%), nausea (1.3%), and headache (1.1%). Local reactions like redness, itching, and swelling are typically mild and temporary.
Pregnancy must be excluded before starting treatment, and it is unknown if cetrorelix acetate is excreted in breast milk; thus, it should not be used by nursing mothers.
